Reduced functional capacity of CD8+ T cells expanded by post-exposure vaccination of γ-herpesvirus-infected CD4-deficient mice

被引:39
作者
Liu, HY [1 ]
Andreansky, S [1 ]
Diaz, G [1 ]
Hogg, T [1 ]
Doherty, PC [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA
关键词
D O I
10.4049/jimmunol.168.7.3477
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mice (1-A(b-/-)) that lack CD4(+) T cells remain healthy for at least three months after respiratory exposure to the murine gamma-her-pesvirus 68 (gammaHV68), then succumb with symptoms of chronic wasting disease. Postexposure challenge of gammaHV68-infected I-A(b+/+) and I-A(b-/-) mice with a recombinant vaccinia virus (Vacc-p56) expressing an antigenic gammaHV68 peptide caused a massive increase in the numbers of D(b)p56-specific CD8(+) T cells. Previous experiments showed that, despite the large numbers of potential CTL effectors, there was little effect on the long-term survival of the CD4-deficient group and no diminution in the level of persistent virus shedding and latency. Comparison of the expanded CD8(+)D(b)p56(+) sets in the I-A(b+/+) and I-A(b-/-) mice indicated that these two T cell populations were not identical. More CD69(high)CD8(+)D(b)p56(+) T cells were found in the CD4-deficient mice, an effect that might be thought to reflect higher Ag load. By contrast, the mean fluorescence intensity of staining for the CD44 glycoprotein was diminished on CD8(+)D(b)p56(+) T cells from the I-A(b-/-) group, the level of CTL activity was lower on a per cell basis, and the relative prevalence of IFN-gamma(+)TNF-alpha(+) T cells detected after in vitro stimulation with the p56 peptide was decreased. Given that this experimental system provides an accessible model for evaluating postexposure vaccination protocols that might be used in diseases like HIV/AIDS, the further need is to clarify the underlying molecular mechanisms and the relative significance of lack of CD4(+) T help vs higher Ag load for these expanded CD8(+) effector populations.
引用
收藏
页码:3477 / 3483
页数:7
相关论文
共 61 条
[1]   Dendritic cells as vectors for therapy [J].
Banchereau, J ;
Schuler-Thurner, B ;
Palucka, AK ;
Schuler, G .
CELL, 2001, 106 (03) :271-274
[2]   ENHANCED ESTABLISHMENT OF A VIRUS CARRIER STATE IN ADULT CD4+ T-CELL-DEFICIENT MICE [J].
BATTEGAY, M ;
MOSKOPHIDIS, D ;
RAHEMTULLA, A ;
HENGARTNER, H ;
MAK, TW ;
ZINKERNAGEL, RM .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4700-4704
[3]   Diversity of epitope and cytokine profiles for primary and secondary influenza A virus-specific CD8+ T cell responses [J].
Belz, GT ;
Xie, WD ;
Doherty, PC .
JOURNAL OF IMMUNOLOGY, 2001, 166 (07) :4627-4633
[4]   Virus-specific and bystander CD8+ T-cell proliferation in the acute and persistent phases of a gammaherpesvirus infection [J].
Belz, GT ;
Doherty, PC .
JOURNAL OF VIROLOGY, 2001, 75 (09) :4435-4438
[5]   Postexposure vaccination massively increases the prevalence of γ-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice [J].
Belz, GT ;
Stevenson, PG ;
Castrucci, MR ;
Altman, JD ;
Doherty, PC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2725-2730
[6]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[7]   Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus [J].
Boshoff, C ;
Weiss, RA .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2001, 356 (1408) :517-534
[8]  
BUDD RC, 1987, J IMMUNOL, V138, P1009
[9]   Progressive loss of CD8(+) T cell-mediated control of a gamma-herpesvirus in the absence of CD4(+) T cells [J].
Cardin, RD ;
Brooks, JW ;
Sarawar, SR ;
Doherty, PC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :863-871
[10]   PHENOTYPIC ANALYSIS OF THE INFLAMMATORY EXUDATE IN MURINE LYMPHOCYTIC CHORIOMENINGITIS [J].
CEREDIG, R ;
ALLAN, JE ;
TABI, Z ;
LYNCH, F ;
DOHERTY, PC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) :1539-1551